Serum Levels of Advanced Glycation End Products (AGEs) are Inversely Associated with the Number and Migratory Activity of Circulating Endothelial Progenitor Cells in Apparently Healthy Subjects

Roles of Oxidative Stress and Redox Regulation in Atherosclerosis

(2011) Takahito Kondo et al.   Journal of Atherosclerosis and Thrombosis

Increased serum levels of methylglyoxal-derived hydroimidazolone-AGE are associated with increased cardiovascular disease mortality in nondiabetic women

(2009) Bente K. Kilhovd et al.   ATHEROSCLEROSIS

Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products

(2009) Chun Liang et al.   BRITISH JOURNAL OF PHARMACOLOGY

Positive association of circulating levels of advanced glycation end products (AGEs) with pigment epithelium-derived factor (PEDF) in a general population

(2009) Sho-ichi Yamagishi et al.   PHARMACOLOGICAL RESEARCH

Advanced Glycation End Products and Receptor–Oxidative Stress System in Diabetic Vascular Complications

(2009) Sho-ichi Yamagishi   THERAPEUTIC APHERESIS AND DIALYSIS

Advanced glycation end-products in senile diabetic and non-diabetic patients with cardiovascular complications

(2008) Anjuman Gul et al.   AGE

Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways

(2008) Chengbo Sun et al.   BASIC RESEARCH IN CARDIOLOGY

Role of Oxidative Stress in the Development of Vascular Injury and its Therapeutic Intervention by Nifedipine

(2008) Sho-ichi Yamagishi et al.   CURRENT MEDICINAL CHEMISTRY

Possible Involvement of Advanced Glycation End-Products (AGEs) in the Pathogenesis of Alzheimers Disease

(2008) Masayoshi Takeuchi et al.   CURRENT PHARMACEUTICAL DESIGN

High-density lipoprotein exerts vasculoprotectionviaendothelial progenitor cells

(2008) Vasileios Petoumenos et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes

(2007) Kazuo Nakamura et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS